{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:48:53Z","timestamp":1778748533802,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00125-018-4633-z","type":"journal-article","created":{"date-parts":[[2018,5,6]],"date-time":"2018-05-06T21:56:53Z","timestamp":1525643813000},"page":"1829-1837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes"],"prefix":"10.1007","volume":"61","author":[{"given":"Brenno","family":"Astiarraga","sequence":"first","affiliation":[]},{"given":"Val\u00e9ria B.","family":"Chueire","sequence":"additional","affiliation":[]},{"given":"Agl\u00e9cio L.","family":"Souza","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Pereira-Moreira","sequence":"additional","affiliation":[]},{"given":"Sarah","family":"Monte Alegre","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Natali","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Tura","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[]},{"given":"Elza","family":"Muscelli","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"key":"4633_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","volume":"1","author":"PJ Randle","year":"1963","unstructured":"Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785\u2013789","journal-title":"Lancet"},{"key":"4633_CR2","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.2337\/diabetes.47.10.1609","volume":"47","author":"G Boden","year":"1998","unstructured":"Boden G, Chen X, Iqbal N (1998) Acute lowering of plasma NEFA lowers basal insulin secretion in diabetic and non diabetic subjects. Diabetes 47:1609\u20131612","journal-title":"Diabetes"},{"key":"4633_CR3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1210\/endo-127-4-1580","volume":"127","author":"Y Sako","year":"1990","unstructured":"Sako Y, Grill VE (1990) A 48-hour lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and \u03b2-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127:1580\u20131589","journal-title":"Endocrinology"},{"key":"4633_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0026-0495(00)80007-4","volume":"49","author":"CM Amery","year":"2000","unstructured":"Amery CM, Round RA, Smith JM, Nattrass M (2000) Elevation of plasma fatty acids by ten-hour intralipid infusion has no effect on basal or glucose-stimulated insulin secretion in normal man. Metabolism 49:450\u2013454","journal-title":"Metabolism"},{"key":"4633_CR5","first-page":"153","volume":"10","author":"JP Felber","year":"1964","unstructured":"Felber JP, Vannotti A (1964) Effects of fat infusion on glucose tolerance and insulin plasma levels. Med Exp Int J Exp Med 10:153\u2013156","journal-title":"Med Exp Int J Exp Med"},{"key":"4633_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2337\/diab.17.2.76","volume":"17","author":"R Pelkonen","year":"1968","unstructured":"Pelkonen R, Miettinen TA, Taskinen MR, Nikkila EA (1968) Effect of acute elevation of plasma glycerol, trygliceride and NEFA levels on glucose utilization and plasma insulin. Diabetes 17:76\u201382","journal-title":"Diabetes"},{"key":"4633_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/BF00401761","volume":"38","author":"G Paolisso","year":"1995","unstructured":"Paolisso G, Gambardella A, Amato L et al (1995) Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295\u20131299","journal-title":"Diabetologia"},{"key":"4633_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.2337\/diab.44.10.1239","volume":"44","author":"G Boden","year":"1995","unstructured":"Boden G, Chen X, Rosner J, Baron M (1995) Effects of a 48-hour fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239\u20131242","journal-title":"Diabetes"},{"key":"4633_CR9","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.2337\/diabetes.52.10.2461","volume":"52","author":"S Kashyap","year":"2003","unstructured":"Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop Type 2 diabetes. Diabetes 52:2461\u20132474","journal-title":"Diabetes"},{"key":"4633_CR10","doi-asserted-by":"publisher","first-page":"E454","DOI":"10.1152\/ajpendo.90613.2008","volume":"296","author":"B Salgin","year":"2009","unstructured":"Salgin B, Marcovecchio ML, Humphreys SM et al (2009) Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects. Am J Physiol Endocrinol Metab 296:E454\u2013E461","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4633_CR11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s001250051041","volume":"41","author":"G Paolisso","year":"1998","unstructured":"Paolisso G, Tagliamonte MR, Rizzo MR et al (1998) Lowering fatty acids potentiates acute insulin response in first degree relatives of people with type II diabetes. Diabetologia 41:1127\u20131132","journal-title":"Diabetologia"},{"key":"4633_CR12","doi-asserted-by":"publisher","first-page":"E255","DOI":"10.1152\/ajpendo.00416.2010","volume":"300","author":"A Giacca","year":"2011","unstructured":"Giacca A, Xiao C, Oprescu AI, Carpentier AC, Lewis GF (2011) Lipid-induced pancreatic \u03b2-cell dysfunction: focus on in vivo studies. Am J Physiol Endocrinol Metab 300:E255\u2013E262","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4633_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1210\/jcem-63-2-492","volume":"63","author":"MA Nauck","year":"1986","unstructured":"Nauck MA, Homberger E, Siegel E et al (1986) Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab 63:492\u2013498","journal-title":"J Clin Endocrinol Metab"},{"key":"4633_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/BF02427280","volume":"29","author":"M Nauck","year":"1986","unstructured":"Nauck M, St\u00f6ckmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46\u201352","journal-title":"Diabetologia"},{"key":"4633_CR15","doi-asserted-by":"publisher","first-page":"E1144","DOI":"10.1152\/ajpendo.00571.2005","volume":"291","author":"E Muscelli","year":"2006","unstructured":"Muscelli E, Mari A, Natali A et al (2006) Impact of incretin hormones on \u03b2-cell function in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 291:E1144\u2013E1150","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4633_CR16","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.2337\/db07-1315","volume":"57","author":"E Muscelli","year":"2008","unstructured":"Muscelli E, Mari A, Casolaro A et al (2008) Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 57:1340\u20131348","journal-title":"Diabetes"},{"key":"4633_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00125-010-1896-4","volume":"54","author":"MA Nauck","year":"2011","unstructured":"Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ (2011) Secretion of glucagon-like peptide-1 (GLP-1) in T2D: what is up, what is down? Diabetologia 54:10\u201318","journal-title":"Diabetologia"},{"key":"4633_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00125-012-2776-x","volume":"56","author":"ZF Kang","year":"2013","unstructured":"Kang ZF, Deng Y, Zhou Y et al (2013) Pharmacological reduction of NEFA restores the efficacy of incretin-based therapies through GLP-1 receptor signalling in the \u03b2-cell in mouse models of diabetes. Diabetologia 56:423\u2013433","journal-title":"Diabetologia"},{"key":"4633_CR19","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1172\/JCI68459","volume":"123","author":"DJ Hodson","year":"2013","unstructured":"Hodson DJ, Mitchell RK, Bellomo LA et al (2013) Lipotoxicity disrupts incretin-regulated human \u03b2-cell connectivity. J Clin Invest 123:4182\u20134194","journal-title":"J Clin Invest"},{"key":"4633_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2337\/diacare.24.3.539","volume":"24","author":"A Mari","year":"2001","unstructured":"Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539\u2013548","journal-title":"Diabetes Care"},{"key":"4633_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00125-014-3219-7","volume":"57","author":"A Tura","year":"2014","unstructured":"Tura A, Muscelli E, Gastaldelli A, Ferrannini E, Mari A (2014) Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic. Diabetologia 57:1199\u20131203","journal-title":"Diabetologia"},{"key":"4633_CR22","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1172\/JCI111133","volume":"72","author":"E Ferrannini","year":"1983","unstructured":"Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA (1983) Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737\u20131747","journal-title":"J Clin Invest"},{"key":"4633_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1017\/S0007114516004475","volume":"117","author":"SA Parry","year":"2017","unstructured":"Parry SA, Smith JR, Corbett TR, Woods RM, Hulston CJ (2017) Short-term, high-fat overfeeding impairs glycaemic control but does not alter gut hormone responses to a mixed meal tolerance test in healthy, normal-weight individuals. Br J Nutr 117:48\u201355","journal-title":"Br J Nutr"},{"key":"4633_CR24","doi-asserted-by":"publisher","first-page":"E1775","DOI":"10.1152\/ajpendo.00624.2006","volume":"292","author":"K Cusi","year":"2007","unstructured":"Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E (2007) Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to T2D. Am J Physiol Endocrinol Metab 292:E1775\u2013E1781","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4633_CR25","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1210\/jc.2012-1205","volume":"97","author":"E Muscelli","year":"2012","unstructured":"Muscelli E, Casolaro A, Gastaldelli A et al (2012) Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes. J Clin Endocrinol Metab 97:2818\u20132826","journal-title":"J Clin Endocrinol Metab"},{"key":"4633_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.2337\/db13-0805","volume":"63","author":"I Vardarli","year":"2014","unstructured":"Vardarli I, Arndt E, Deacon CF, Holst JJ, Nauck MA (2014) Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and \u201cisoglycemic\u201d intravenous glucose. Diabetes 63:663\u2013674","journal-title":"Diabetes"},{"key":"4633_CR27","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1007\/s00125-015-3685-6","volume":"58","author":"E Rebelos","year":"2015","unstructured":"Rebelos E, Seghieri M, Natali A et al (2015) Influence of endogenous NEFA on beta cell function in humans. Diabetologia 58:2344\u20132351","journal-title":"Diabetologia"},{"key":"4633_CR28","doi-asserted-by":"crossref","unstructured":"Poitout V, Robertson RP (2008) Glucolipotoxicity: Fuel excess and \u03b2-cell dysfunction. Endocr Rev 29:351\u2013366","DOI":"10.1210\/er.2007-0023"},{"key":"4633_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.mce.2013.07.025","volume":"381","author":"S Meidute Abaraviciene","year":"2013","unstructured":"Meidute Abaraviciene S, Muhammed SJ, Amisten S, Lundquist I, Salehi A (2013) GPR40 protein levels are crucial to the regulation of stimulated hormone secretion in pancreatic islets. Lessons from spontaneous obesity-prone and non-obese type 2 diabetes in rats. Mol Cell Endocrinol 381:150\u2013159","journal-title":"Mol Cell Endocrinol"},{"key":"4633_CR30","first-page":"1584","volume":"80","author":"YP Zhou","year":"1995","unstructured":"Zhou YP, Grill V (1995) Long term exposure to fatty acids and ketones inhibits B cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 80:1584\u20131590","journal-title":"J Clin Endocrinol Metab"},{"key":"4633_CR31","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2337\/db06-1033","volume":"56","author":"G Xu","year":"2007","unstructured":"Xu G, Kaneto H, Laybutt DR et al (2007) Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes 56:1551\u20131558","journal-title":"Diabetes"},{"key":"4633_CR32","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.numecd.2017.10.006","volume":"27","author":"A Tura","year":"2017","unstructured":"Tura A, Bagger JI, Ferrannini E et al (2017) Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response. Nutr Metab Cardiovasc Dis 27:1123\u20131129","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"4633_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jdiacomp.2016.04.005","volume":"30","author":"A Tanabe","year":"2016","unstructured":"Tanabe A, Kaneto H, Kamei S et al (2016) Clinical effects of liraglutide are possibly influenced by hypertriglyceridemia and remaining pancreatic \u03b2-cell function in subjects with type 2 diabetes mellitus. J Diabetes Complicat 30:1201\u20131203","journal-title":"J Diabetes Complicat"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4633-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4633-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4633-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T13:08:55Z","timestamp":1557407335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4633-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4633"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4633-z","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,7]]},"assertion":[{"value":"26 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}